LifeHealth is dedicated to the point-of-care diagnostics market by providing products that enable early disease detection to improve human and animal health. Our philosophy is that early detection is the most effective way to improve the quality of human life and to reduce the cost of care. The Company’s first commercial product line is the IRMA TruPoint Blood Analysis System, the world’s first point-of-care product line for detecting blood gases, which LifeHealth acquired in 2014. For over two decades, this system has been at the forefront of providing instant critical lab results to clinicians. The system has delivered quality clinical performance since its inception. LifeHealth is developing additional novel proprietary assays to further advance public health. These new developments and improvements promise to change the standard of cardiovascular screening and disease monitoring worldwide.